We believe that genetics holds vital clues to understanding and treating most diseases, and that exploring diverse genetics sets will lead to finding better, more inclusive therapies.

We’re a neuroscience company building genetically diverse and physiologically relevant organoid-based disease models for complex neurological diseases, in order to help advance drug discovery and development.

Recent Posts

image from Illumina Accelerator

Illumina Accelerator

read more